208 related articles for article (PubMed ID: 38244540)
21. UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity.
Zhong J; Zhao M; Ma Y; Luo Q; Liu J; Wang J; Yuan X; Sang J; Huang C
Int J Mol Med; 2012 Aug; 30(2):430-6. PubMed ID: 22641175
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease.
Wilson CL; Murphy LB; Leslie J; Kendrick S; French J; Fox CR; Sheerin NS; Fisher A; Robinson JH; Tiniakos DG; Gray DA; Oakley F; Mann DA
J Hepatol; 2015 Dec; 63(6):1421-8. PubMed ID: 26264933
[TBL] [Abstract][Full Text] [Related]
23. UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α.
Goto Y; Zeng L; Yeom CJ; Zhu Y; Morinibu A; Shinomiya K; Kobayashi M; Hirota K; Itasaka S; Yoshimura M; Tanimoto K; Torii M; Sowa T; Menju T; Sonobe M; Kakeya H; Toi M; Date H; Hammond EM; Hiraoka M; Harada H
Nat Commun; 2015 Jan; 6():6153. PubMed ID: 25615526
[TBL] [Abstract][Full Text] [Related]
24. UCHL1 Regulates Radiation Lung Injury via Sphingosine Kinase-1.
Epshtein Y; Mathew B; Chen W; Jacobson JR
Cells; 2023 Oct; 12(19):. PubMed ID: 37830619
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin C-terminal hydrolase L1 (UCHL1) regulates post-myocardial infarction cardiac fibrosis through glucose-regulated protein of 78 kDa (GRP78).
Lei Q; Yi T; Li H; Yan Z; Lv Z; Li G; Wang Y
Sci Rep; 2020 Jun; 10(1):10604. PubMed ID: 32606430
[TBL] [Abstract][Full Text] [Related]
26. UCHL1-PKM2 axis dysregulation is associated with promoted proliferation and invasiveness of urothelial bladder cancer cells.
Zheng Y; Shi D; Chen L; Yang Y; Yao M
Aging (Albany NY); 2023 Oct; 15(19):10593-10606. PubMed ID: 37815895
[TBL] [Abstract][Full Text] [Related]
27. Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity.
Panyain N; Godinat A; Lanyon-Hogg T; Lachiondo-Ortega S; Will EJ; Soudy C; Mondal M; Mason K; Elkhalifa S; Smith LM; Harrigan JA; Tate EW
J Am Chem Soc; 2020 Jul; 142(28):12020-12026. PubMed ID: 32579346
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions.
Chu KY; Li H; Wada K; Johnson JD
Diabetologia; 2012 Jan; 55(1):128-40. PubMed ID: 22038515
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor.
Krabill AD; Chen H; Hussain S; Feng C; Abdullah A; Das C; Aryal UK; Post CB; Wendt MK; Galardy PJ; Flaherty DP
Chembiochem; 2020 Mar; 21(5):712-722. PubMed ID: 31449350
[TBL] [Abstract][Full Text] [Related]
30. Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1.
Imhoff RD; Patel R; Safdar MH; Jones HBL; Pinto-Fernandez A; Vendrell I; Chen H; Muli CS; Krabill AD; Kessler BM; Wendt MK; Das C; Flaherty DP
J Med Chem; 2024 Mar; 67(6):4496-4524. PubMed ID: 38488146
[TBL] [Abstract][Full Text] [Related]
31. High Expression of Ubiquitin C-terminal Hydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients.
Nakao K; Hirakawa T; Suwa H; Kogure K; Ikeda S; Yamashita S; Minegishi T; Kishi H
Int J Gynecol Cancer; 2018 May; 28(4):675-683. PubMed ID: 29489474
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.
Seliger B; Handke D; Schabel E; Bukur J; Lichtenfels R; Dammann R
J Transl Med; 2009 Oct; 7():90. PubMed ID: 19857250
[TBL] [Abstract][Full Text] [Related]
33. The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK).
Davies CW; Chaney J; Korbel G; Ringe D; Petsko GA; Ploegh H; Das C
Bioorg Med Chem Lett; 2012 Jun; 22(12):3900-4. PubMed ID: 22617491
[TBL] [Abstract][Full Text] [Related]
34. Small-Molecule Activity-Based Probe for Monitoring Ubiquitin C-Terminal Hydrolase L1 (UCHL1) Activity in Live Cells and Zebrafish Embryos.
Kooij R; Liu S; Sapmaz A; Xin BT; Janssen GMC; van Veelen PA; Ovaa H; Dijke PT; Geurink PP
J Am Chem Soc; 2020 Sep; 142(39):16825-16841. PubMed ID: 32886496
[TBL] [Abstract][Full Text] [Related]
35. Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.
Zhang M; Deng Y; Luo Y; Zhang S; Zou H; Cai F; Wada K; Song W
J Neurochem; 2012 Mar; 120(6):1129-38. PubMed ID: 22212137
[TBL] [Abstract][Full Text] [Related]
36. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma.
Li L; Tao Q; Jin H; van Hasselt A; Poon FF; Wang X; Zeng MS; Jia WH; Zeng YX; Chan AT; Cao Y
Clin Cancer Res; 2010 Jun; 16(11):2949-58. PubMed ID: 20395212
[TBL] [Abstract][Full Text] [Related]
37. Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma.
Lee KC; Chen HH; Cheng KC; Liu TT; Lee KF; Teng CC; Huang CY; Hsieh MC; Kuo HC
J Cell Mol Med; 2023 Jul; 27(14):2004-2020. PubMed ID: 37246623
[TBL] [Abstract][Full Text] [Related]
38. The Suppression of Ubiquitin C-Terminal Hydrolase L1 Promotes the Transdifferentiation of Auditory Supporting Cells into Hair Cells by Regulating the mTOR Pathway.
Kim YJ; Jeong IH; Ha JH; Kim YS; Sung S; Jang JH; Choung YH
Cells; 2024 Apr; 13(9):. PubMed ID: 38727276
[TBL] [Abstract][Full Text] [Related]
39. [The role of hypermethylation in promoter region of ubiquitin carboxyl-terminal hydrolase L1 in human esophageal cancer].
Yan WJ; Guo MZ; Yang YS
Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):390-3. PubMed ID: 22883340
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin C-terminal hydrolase isozyme L1 is associated with shelterin complex at interstitial telomeric sites.
Ilic A; Lu S; Bhatia V; Begum F; Klonisch T; Agarwal P; Xu W; Davie JR
Epigenetics Chromatin; 2017 Nov; 10(1):54. PubMed ID: 29126443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
